Targeting HSF1 as a Therapeutic Strategy for Multiple Mechanisms of EGFR Inhibitor Resistance in EGFR Mutant Non-Small-Cell Lung Cancer

SIMPLE SUMMARY: We attempted to identify target proteins and compounds that can be used to overcome EGFR-TKI resistance in NSCLC. To accomplish this, we generated EGFR inhibitor erlotinib-resistant HCC827-ErlR cells and obtained a list of differentially expressed genes. Then, we performed connectivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sangah, Jung, Jiyae, Lee, Yu-Jin, Kim, Seon-Kyu, Kim, Jung-Ae, Kim, Bo-Kyung, Park, Kyung Chan, Kwon, Byoung-Mog, Han, Dong Cho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232331/
https://www.ncbi.nlm.nih.gov/pubmed/34203709
http://dx.doi.org/10.3390/cancers13122987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232331/
https://www.ncbi.nlm.nih.gov/pubmed/34203709
http://dx.doi.org/10.3390/cancers13122987

Ejemplares similares